ZA741441B - Herpes simplex type 2 virus vaccine and method of production and use - Google Patents

Herpes simplex type 2 virus vaccine and method of production and use

Info

Publication number
ZA741441B
ZA741441B ZA00741441A ZA741441A ZA741441B ZA 741441 B ZA741441 B ZA 741441B ZA 00741441 A ZA00741441 A ZA 00741441A ZA 741441 A ZA741441 A ZA 741441A ZA 741441 B ZA741441 B ZA 741441B
Authority
ZA
South Africa
Prior art keywords
production
herpes simplex
virus vaccine
simplex type
type
Prior art date
Application number
ZA00741441A
Other languages
English (en)
Inventor
N Zygraich
C Huygelen
Original Assignee
Rit Rech Ind Therapeut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rit Rech Ind Therapeut filed Critical Rit Rech Ind Therapeut
Publication of ZA741441B publication Critical patent/ZA741441B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/01—Preparation of mutants without inserting foreign genetic material therein; Screening processes therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/821—Drug, bio-affecting and body treating compositions involving temperature-sensitive mutant virus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
ZA00741441A 1973-03-30 1974-03-05 Herpes simplex type 2 virus vaccine and method of production and use ZA741441B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1530773A GB1390467A (en) 1973-03-30 1973-03-30 Vaccination method using temperature sensitive virus mutants

Publications (1)

Publication Number Publication Date
ZA741441B true ZA741441B (en) 1975-02-26

Family

ID=10056766

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA00741441A ZA741441B (en) 1973-03-30 1974-03-05 Herpes simplex type 2 virus vaccine and method of production and use

Country Status (10)

Country Link
US (1) US3897549A (de)
JP (1) JPS6035327B2 (de)
BE (1) BE812816A (de)
CA (1) CA1021261A (de)
DE (1) DE2415353A1 (de)
FR (1) FR2223004B1 (de)
GB (1) GB1390467A (de)
HU (1) HU169253B (de)
NL (1) NL7404054A (de)
ZA (1) ZA741441B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4374127A (en) * 1977-09-19 1983-02-15 Merck & Co., Inc. Herpes sub unit vaccine
US4452734A (en) * 1980-02-11 1984-06-05 Merck & Co., Inc. Herpes subunit vaccine
US4554159A (en) * 1981-11-12 1985-11-19 Institute Merieux Vaccine and method of immunizing against herpes simplex virus (types 1 and 2)
US4618493A (en) * 1982-10-13 1986-10-21 Smithkline-Rit Temperature sensitive strains of bovine viral diarrhoea virus, preparation thereof and vaccines containing them
US4714678A (en) * 1982-10-13 1987-12-22 Smithkline-Rit Temperature sensitive strain of bovine viral diarrhoea virus

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4848621A (de) * 1971-10-20 1973-07-10
DE2215728C3 (de) * 1972-03-30 1979-02-15 Stickl, Helmut, Prof. Dr.Med., 8033 Krailling Arzneimittel zur Behandlung von Herpes simplex

Also Published As

Publication number Publication date
FR2223004B1 (de) 1978-01-06
NL7404054A (de) 1974-10-02
CA1021261A (en) 1977-11-22
AU6708674A (en) 1975-09-25
US3897549A (en) 1975-07-29
HU169253B (de) 1976-10-28
DE2415353C2 (de) 1987-10-01
BE812816A (fr) 1974-09-26
DE2415353A1 (de) 1974-10-03
GB1390467A (en) 1975-04-16
JPS5029736A (de) 1975-03-25
FR2223004A1 (de) 1974-10-25
JPS6035327B2 (ja) 1985-08-14

Similar Documents

Publication Publication Date Title
ZA742358B (en) Shaped and fired articles of tio2
ZA74540B (en) Novel electrodes and their preparations
ZA742186B (en) Penicillin and their preparation
IL44766A0 (en) Preparation of brominated pentaerythritols and esters
IL46926A0 (en) The preparation of 2-arylamino-2-imidazoline derivatives and certain novel 2-dihaloarylamino-2-imidazoline derivatives
IL44143A0 (en) Method of inactivating viruses and vaccines prepared thereby
JPS51133414A (en) Production of vaccine against viral hepatisis
JPS5282721A (en) Production of chcken poxx herpes zoster virus vaccine
ZA75179B (en) New arylpiperazine derivatives of adenine and the preparation thereof
ZA741441B (en) Herpes simplex type 2 virus vaccine and method of production and use
IL46426A (en) Influenza vaccines and their production
IL46423A0 (en) 5:6-benzo-gamma-pyrone derivatives and process for their preparation
ZA751560B (en) Pyrimidin-6-yl acethydroxamic acids, their process of preparation and their therapeutic application
CH608018A5 (en) Process for the preparation of oligocarboxyalkanephosphonic acids and their use
ZA746398B (en) Preparation of vaccines
CH611338A5 (en) Process for the preparation of inactivated HB-Ag vaccines
PH10333A (en) 6-substituted 3-carbethoxyhydrazinopyridazines and method of preparation thereof
AU486997B2 (en) Herpes simplex type 2 virus vaccine and method of production and use
ZA745309B (en) Adenine derivatives and preparation thereof
IL45181A0 (en) Vaccine and its preparation
GR58472B (en) Pseudotrisacharites and process of their preparation
PH13202A (en) 15-substituted prostanoic acids and method of use
ZA745656B (en) 6-trichloroacetamido-penicillanic acid derivatives and their preparation
MW4174A1 (en) Penam derivatives and preparation thereof
ZA742522B (en) Process for the preparation of itaconic acid and derivatives thereof